Monte Rosa Therapeutics's market cap is currently $402.41M. The company's EPS TTM is $-1.832; its P/E ratio is ―; Monte Rosa Therapeutics is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $0.18. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -6.22M	$ -8.56M	$ -2.13M	$ -537.00K	$ -72.00K
Operating Income	$ -143.31M	$ -112.38M	$ -72.88M	$ -28.01M	$ -7.99M
EBITDA	$ -137.09M	$ -99.94M	$ -70.75M	$ -27.47M	$ -7.67M
Net Income	$ -135.35M	$ -104.62M	$ -71.94M	$ -36.07M	$ -8.02M
Balance Sheet
Cash & Short-Term Investments	$ 232.41M	$ 262.83M	$ 346.07M	$ 41.70M	$ 6.00M
Total Assets	$ 303.75M	$ 342.39M	$ 366.33M	$ 49.38M	$ 11.09M
Total Debt	$ 46.04M	$ 47.00M	$ 0.00	$ 67.76M	$ 750.00K
Net Debt	$ -82.06M	$ -7.91M	$ -346.07M	$ 26.07M	$ -5.25M
Total Liabilities	$ 124.50M	$ 70.98M	$ 18.81M	$ 98.11M	$ 23.24M
Stockholders' Equity	$ 179.25M	$ 271.41M	$ 347.51M	$ -48.73M	$ -12.15M
Cash Flow
Free Cash Flow	$ -62.84M	$ -105.38M	$ -69.09M	$ -26.44M	$ -7.56M
Operating Cash Flow	$ -43.80M	$ -92.47M	$ -59.36M	$ -23.05M	$ -6.17M
Investing Cash Flow	$ 88.80M	$ -219.22M	$ -9.65M	$ -3.39M	$ -1.39M
Financing Cash Flow	$ 27.49M	$ 20.47M	$ 377.56M	$ 60.06M	$ 15.00M

Currency in USD

Monte Rosa Therapeutics Earnings and Revenue History

Income Statement >

Monte Rosa Therapeutics Debt to Assets

Balance Sheet >

Monte Rosa Therapeutics Cash Flow

Cash Flow >

Monte Rosa Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing